Nanoparticles targeting the adenosine pathway for cancer immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nanoparticles targeting the adenosine pathway for cancer immunotherapy

Published:2024 Issue:24 Volume:12 Page:5787-5811
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Jiang Kehua¹,Wu Jian²,Wang Qing¹^ORCID,Chen Xiaolong¹,Zhang Yanlong¹,Gu Xiaoya¹³,Tang Kun²^ORCID

Affiliation:

1. Department of Urology, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China

2. Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095, Jiefang Avenue, Qiaokou District, Wuhan, Hubei, 430030, China

3. Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China

Abstract

Outline of this review on adenosine pathway inhibitors for cancer immunotherapy.

Funder

Guizhou Provincial Science and Technology Department

National Natural Science Foundation of China

Science and Technology Program of Guizhou Province

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/TB/D4TB00292J

Reference149 articles.

1. Advancing to the era of cancer immunotherapy

2. Cancer immunotherapies: advances and bottlenecks

3. Role of the tumor immune microenvironment in tumor immunotherapy (Review)

4. Adenosine Blockage in Tumor Microenvironment and Improvement of Cancer Immunotherapy

5. Immunosuppressive adenosine-targeted biomaterials for emerging cancer immunotherapy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP